Non‐amnesic preclinical traits in autosomal dominant Alzheimer's disease: Executive functions in <i>APP</i> <sub>V717I</sub> Mexican carriers

While memory problems are frequently reported in preclinical carriers of other ADAD mutations, our PC- APP<sub>V717I</sub> and NC groups scored similarly on memory tasks. However, we found preclinical difficulties in the MWCST, which assesses cognitive flexibility. YoS is positively correlated and predicts this result. To our knowledge, no published studies report preclinical EF performance in any of the APP mutations, so our work marks a precedent in exploring EF in APPV717I through this stage, being this the most frequently identified APP mutation worldwide.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70857_105651
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Non‐amnesic preclinical traits in autosomal dominant Alzheimer's disease: Executive functions in APP V717I Mexican carriers

Esmeralda Matute, Angélica Zuno‐Reyes, John M. Ringman, Sofía Dumois‐Petersen et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Non‐amnesic preclinical traits in autosomal dominant Alzheimer's disease: Executive functions in APP V717I Mexican carriers

Esmeralda Matute, Angélica Zuno‐Reyes, John M. Ringman, Sofía Dumois‐Petersen, Ricardo Jauregui Torres, Figuera Luis E., Karina Pérez‐Rubio
article en

Abstract

While memory problems are frequently reported in preclinical carriers of other ADAD mutations, our PC- APP<sub>V717I</sub> and NC groups scored similarly on memory tasks. However, we found preclinical difficulties in the MWCST, which assesses cognitive flexibility. YoS is positively correlated and predicts this result. To our knowledge, no published studies report preclinical EF performance in any of the APP mutations, so our work marks a precedent in exploring EF in APPV717I through this stage, being this the most frequently identified APP mutation worldwide.

Alzheimer s & DementiaVol. 21(S3)
University of Southern California (US), Mexican Social Security Institute (MX), Universidad de Guadalajara (MX)
Openalex Percentile: Top 33%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Non‐amnesic preclinical traits in autosomal dominant Alzheimer's disease: Executive functions in <i>APP</i> <sub>V717I</sub> Mexican carriers — Esmeralda Matute, Angélica Zuno‐Reyes, et al. · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS